E-LIB Suche - Ergebnisse für: Freeman, Mason W.

1

Results from a Phase 1 Study Assessing the Pharmacokinetics..:

Freeman, Mason W. ; Halvorsen, Yuan‐Di ; Bond, Mary..
Clinical Pharmacology in Drug Development. 13 (2024) 4 - p. 410-418 , 2024

Link: https://doi.org/10.1002/..

2

Results From a Randomized, Open-Label, Crossover Study Eval..:

Freeman, Mason W. ; Bond, Mary ; Murphy, Brian..
American Journal of Cardiovascular Drugs. 23 (2023) 3 - p. 277-286 , 2023

Link: https://doi.org/10.1007/..

3

Meta‐analysis of risk of major adverse cardiovascular event..:

McMurray, John J. V. ; Solomon, Scott D. ; Lock, J. Paul...
Diabetes, Obesity and Metabolism. 26 (2023) 3 - p. 971-979 , 2023

Link: https://doi.org/10.1111/..

4

Bexagliflozin as an adjunct to metformin for the treatment ..:

Halvorsen, Yuan‐Di ; Conery, Annie L. ; Lock, John Paul..
Diabetes, Obesity and Metabolism. 25 (2023) 10 - p. 2954-2962 , 2023

Link: https://doi.org/10.1111/..

5

Results from a phase 1, randomized, double-blind, multiple ..:

Freeman, Mason W. ; Bond, Mary ; Murphy, Brian..
Hypertension Research. 46 (2022) 1 - p. 108-118 , 2022

Link: https://doi.org/10.1038/..

6

Results from a Randomized, Open-Label, Crossover Study Eval..:

Freeman, Mason W. ; Bond, Mary ; Murphy, Brian..
American Heart Journal. 254 (2022) - p. 245 , 2022

Link: https://doi.org/10.1016/..

7

A 96‐week, double‐blind, randomized controlled trial compar..:

Halvorsen, Yuan‐Di ; Lock, John Paul ; Frias, Juan P....
Diabetes, Obesity and Metabolism. 25 (2022) 1 - p. 293-301 , 2022

Link: https://doi.org/10.1111/..

8

An overview of the process, progress, and outcomes of a Nat..:

Antman, Elliott M. ; Freeman, Mason W. ; Golan, David E....
Journal of Clinical and Translational Science. 5 (2021) 1 - p. , 2021

Link: https://doi.org/10.1017/..

9

A 96‐week, multinational, randomized, double‐blind, paralle..:

Halvorsen, Yuan‐Di C. ; Walford, Geoffrey A. ; Massaro, Joseph..
Diabetes, Obesity and Metabolism. 21 (2019) 11 - p. 2496-2504 , 2019

Link: https://doi.org/10.1111/..

10

A 12‐week, randomized, double‐blind, placebo‐controlled, fo..:

Halvorsen, Yuan‐Di ; Walford, Geoffrey ; Thurber, Tara...
Diabetes, Obesity and Metabolism. 22 (2019) 4 - p. 566-573 , 2019

Link: https://doi.org/10.1111/..

11

Safety and Effectiveness of Bexagliflozin in Patients With ..:

Allegretti, Andrew S. ; Zhang, Wenbin ; Zhou, Wenjiong...
American Journal of Kidney Diseases. 74 (2019) 3 - p. 328-337 , 2019

Link: https://doi.org/10.1053/..

12

A 24‐week, randomized, double‐blind, active‐controlled clin..:

Halvorsen, Yuan‐Di ; Lock, John P. ; Zhou, Wenjiong..
Diabetes, Obesity and Metabolism. 21 (2019) 10 - p. 2248-2256 , 2019

Link: https://doi.org/10.1111/..

13

Long‐term effects of patiromer for hyperkalaemia treatment ..:

Pitt, Bertram ; Bakris, George L. ; Weir, Matthew R....
ESC Heart Failure. 5 (2018) 4 - p. 592-602 , 2018

Link: https://doi.org/10.1002/..

14

Contributors:

, In: Endocrinology: Adult and Pediatric,

Aiello, Lloyd Paul ; Alatzoglou, Kyriaki S. ; Alexander, Erik K.... - p. iii-xvi , 2016

Link: https://doi.org/10.1016/..

15

Lipoprotein Metabolism and the Treatment of Lipid Disorders:

, In: Endocrinology: Adult and Pediatric,

Freeman, Mason W. ; Walford, Geoffrey A. - p. 715-736.e7 , 2016

Link: https://doi.org/10.1016/..